IL52101A - Pharmaceutical compositions containing dihydroergotamine and etilefrine - Google Patents
Pharmaceutical compositions containing dihydroergotamine and etilefrineInfo
- Publication number
- IL52101A IL52101A IL52101A IL5210177A IL52101A IL 52101 A IL52101 A IL 52101A IL 52101 A IL52101 A IL 52101A IL 5210177 A IL5210177 A IL 5210177A IL 52101 A IL52101 A IL 52101A
- Authority
- IL
- Israel
- Prior art keywords
- etilefrine
- pharmaceutical compositions
- compositions containing
- containing dihydroergotamine
- dihydroergotamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/02—Ergot alkaloids of the cyclic peptide type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19762621906 DE2621906A1 (en) | 1976-05-17 | 1976-05-17 | NEW THERAPEUTIC MIXTURE AND METHOD FOR PRODUCING IT |
Publications (2)
Publication Number | Publication Date |
---|---|
IL52101A0 IL52101A0 (en) | 1977-07-31 |
IL52101A true IL52101A (en) | 1980-01-31 |
Family
ID=5978199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL52101A IL52101A (en) | 1976-05-17 | 1977-05-16 | Pharmaceutical compositions containing dihydroergotamine and etilefrine |
Country Status (22)
Country | Link |
---|---|
JP (1) | JPS52139730A (en) |
AT (1) | AT366574B (en) |
AU (1) | AU513718B2 (en) |
BE (1) | BE854694A (en) |
CA (1) | CA1088865A (en) |
CS (1) | CS207455B2 (en) |
DE (1) | DE2621906A1 (en) |
ES (1) | ES458819A1 (en) |
FR (1) | FR2351657A1 (en) |
GB (1) | GB1565447A (en) |
GR (1) | GR72995B (en) |
HK (1) | HK3283A (en) |
HU (1) | HU175167B (en) |
IE (1) | IE45197B1 (en) |
IL (1) | IL52101A (en) |
MY (1) | MY8400062A (en) |
NL (1) | NL177981C (en) |
NZ (1) | NZ184111A (en) |
PH (1) | PH20257A (en) |
PT (1) | PT66552B (en) |
SE (1) | SE425545B (en) |
ZA (1) | ZA772935B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2935515A1 (en) * | 1979-09-03 | 1981-03-19 | Fa. Dr. Willmar Schwabe, 7500 Karlsruhe | MEDICINAL PRODUCT |
JPH0227013U (en) * | 1988-08-10 | 1990-02-22 | ||
CA2368587A1 (en) | 1999-03-26 | 2000-10-05 | John R. Plachetka | High potency dihydroergotamine compositions |
-
1976
- 1976-05-17 DE DE19762621906 patent/DE2621906A1/en active Granted
-
1977
- 1977-05-09 SE SE7705340A patent/SE425545B/en not_active IP Right Cessation
- 1977-05-12 FR FR7714507A patent/FR2351657A1/en active Granted
- 1977-05-13 PH PH19768A patent/PH20257A/en unknown
- 1977-05-13 GB GB20210/77A patent/GB1565447A/en not_active Expired
- 1977-05-13 NL NLAANVRAGE7705306,A patent/NL177981C/en not_active IP Right Cessation
- 1977-05-16 AT AT0347677A patent/AT366574B/en not_active IP Right Cessation
- 1977-05-16 JP JP5624877A patent/JPS52139730A/en active Granted
- 1977-05-16 ES ES458819A patent/ES458819A1/en not_active Expired
- 1977-05-16 IL IL52101A patent/IL52101A/en unknown
- 1977-05-16 IE IE1001/77A patent/IE45197B1/en unknown
- 1977-05-16 CS CS773204A patent/CS207455B2/en unknown
- 1977-05-16 CA CA278,488A patent/CA1088865A/en not_active Expired
- 1977-05-16 PT PT66552A patent/PT66552B/en unknown
- 1977-05-16 NZ NZ184111A patent/NZ184111A/en unknown
- 1977-05-16 HU HU77SA3035A patent/HU175167B/en not_active IP Right Cessation
- 1977-05-16 AU AU25169/77A patent/AU513718B2/en not_active Expired
- 1977-05-16 BE BE177623A patent/BE854694A/en not_active IP Right Cessation
- 1977-05-17 ZA ZA00772935A patent/ZA772935B/en unknown
- 1977-05-17 GR GR53485A patent/GR72995B/el unknown
-
1983
- 1983-01-20 HK HK32/83A patent/HK3283A/en unknown
-
1984
- 1984-12-30 MY MY62/84A patent/MY8400062A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BE854694A (en) | 1977-11-16 |
GB1565447A (en) | 1980-04-23 |
FR2351657A1 (en) | 1977-12-16 |
IE45197B1 (en) | 1982-07-14 |
GR72995B (en) | 1984-01-24 |
HU175167B (en) | 1980-05-28 |
ATA347677A (en) | 1981-09-15 |
CA1088865A (en) | 1980-11-04 |
HK3283A (en) | 1983-01-20 |
NZ184111A (en) | 1980-02-21 |
PT66552A (en) | 1977-06-01 |
MY8400062A (en) | 1984-12-31 |
ZA772935B (en) | 1979-01-31 |
AT366574B (en) | 1982-04-26 |
AU2516977A (en) | 1978-11-23 |
NL177981B (en) | 1985-08-01 |
PH20257A (en) | 1986-11-14 |
JPS628413B2 (en) | 1987-02-23 |
IL52101A0 (en) | 1977-07-31 |
FR2351657B1 (en) | 1980-01-18 |
DE2621906A1 (en) | 1977-12-01 |
AU513718B2 (en) | 1980-12-18 |
ES458819A1 (en) | 1978-08-01 |
NL177981C (en) | 1986-01-02 |
CS207455B2 (en) | 1981-07-31 |
JPS52139730A (en) | 1977-11-21 |
SE7705340L (en) | 1977-11-18 |
DE2621906C2 (en) | 1988-04-21 |
PT66552B (en) | 1979-09-03 |
IE45197L (en) | 1977-11-17 |
NL7705306A (en) | 1977-11-21 |
SE425545B (en) | 1982-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA771998B (en) | Triazolo-pyrimidines and pharmaceutical compositions containing them | |
IL51660A0 (en) | Hentriakontapeptides their preparation and pharmaceutical compositions containing them | |
GB1546747A (en) | Antibacterial pharmaceutical and feestuff compositions | |
NZ185356A (en) | 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them | |
NZ185986A (en) | 2-oxa-bicyclic prostag-landins and pharmaceutical compositions | |
NZ183551A (en) | Aminochromanols and pharmaceutical compositions containingthem | |
NZ185358A (en) | Spiro-hydantoins and pharmaceutical compositions | |
NZ183134A (en) | I-i-(3-aryloxy-2-hydroxypropyl)-4-piperidyl-3-aryl-imid-azolidin or hexahydropyrimidin-2-ones; and pharmaceutical compositions | |
NZ184428A (en) | N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions | |
IL52433A (en) | 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine and pharmaceutical compositions containing them | |
JPS5315367A (en) | 22benzilpyrrolidine* preparation thereof and medicine containing same | |
JPS52111552A (en) | 44androstenee33one and preparation thereof | |
NZ184912A (en) | 2-phenylamino-imidazolines and pharmaceutical compositions | |
JPS5362834A (en) | Pharmaceutical composition and use thereof | |
NZ184735A (en) | Peptides and pharmaceutical compositions | |
IL52409A (en) | 5-m-tolyloxyuracil and pharmaceutical compositions containing it | |
IL51572A0 (en) | New substituted purines and pharmaceutical compositions containing them | |
NZ183549A (en) | Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions | |
PH12590A (en) | 4a-aryl octahydro-1h-2-pyrindines and pharmaceutical composition thereof | |
NZ185296A (en) | Corticoids and pharmaceutical compositions | |
NZ185341A (en) | 19-oxygenated steroids and pharmaceutical compositions | |
JPS5320433A (en) | Pharmaceutical composition and application | |
JPS52131534A (en) | Aralkylarylamine and preparation thereof | |
JPS5291859A (en) | 22furanones and preparation thereof | |
IL52101A (en) | Pharmaceutical compositions containing dihydroergotamine and etilefrine |